PRODUCT OVERVIEW & COMPOSITION
Brand / Manufacturer: Bioniche Pharma
Brand / Product Name: CLOMI-MED
Active Ingredient: Clomiphene Citrate USP (50 mg per tablet)
Pharmacological Class: Selective Estrogen Receptor Modulator (SERM)
Bioniche Pharma CLOMI-MED contains Clomiphene Citrate, a synthetic non-steroidal agent possessing both estrogenic and anti-estrogenic properties. It operates through tissue-specific binding to estrogen receptors, primarily displacing endogenous estrogen at the hypothalamic level to stimulate gonadotropin release.
CLINICAL PHARMACOLOGY & CHARACTERISTICS
As a selective estrogen receptor modulator, Bioniche Pharma CLOMI-MED exerts tissue-selective antagonist or agonist activity depending on the target organ. By blocking estrogenic negative feedback at the hypothalamus and anterior pituitary gland, it prompts an increase in the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), thereby inducing follicular maturation and triggering ovulation.
INDICATIONS & CLINICAL USE
- Treatment of ovulatory dysfunction and anovulatory infertility in women desiring pregnancy (including patients with polycystic ovary syndrome / PCOS) using Bioniche Pharma formulations.
- Therapeutic induction of ovulation following thorough diagnostic evaluation to rule out underlying organic or systemic impediments to conception under Bioniche Pharma medical supervision.
DOSAGE & ADMINISTRATION
Treatment protocols for Bioniche Pharma CLOMI-MED must be individualised and administered under direct medical supervision. Regimens typically involve cycling courses initiated on specific days of the menstrual cycle, with dosage adjustments guided by clinical ovarian response and monitoring.
ADVERSE REACTIONS & PRECAUTIONS
Clinical side effects are generally dose-related and transient upon therapy cessation during Bioniche Pharma treatment:
- Ovarian Effects: Reversible ovarian enlargement, pelvic pain, or functional cyst development associated with Bioniche Pharma CLOMI-MED administration.
- Ocular Disturbances: Dose-dependent visual blurring, scotomas, or photophobia. Treatment should be discontinued immediately if visual symptoms occur during Bioniche Pharma therapy.
- Vasomotor & Abdominal Symptoms: Hot flashes, abdominal distension, bloating, and discomfort reported by patients using Bioniche Pharma formulations.
STORAGE & HANDLING
Store Bioniche Pharma products in a cool, dry place away from direct sunlight, excess heat, and humidity. Keep strictly out of reach and sight of children.